兆豐股份(300695.SZ):三個募投項目擬延期一年
格隆匯 11 月 11日丨兆豐股份(300695.SZ)公告,公司於2020年11月10日召開第四屆董事會第十四次會議、第四屆監事會第十四次會議,審議通過了《關於部分募集資金投資項目延期的議案》,同意公司在募集資金投資項目實施主體、募集資金投資用途及規模不發生變更的情況下,對部分募集資金投資項目進行延期。
本次進行延期的募集資金投資項目為“年產360萬套汽車輪轂軸承單元擴能項目”、“企業技術中心升級改造項目”和“年產3,000萬隻汽車輪轂軸承單元精密鍛車件智能化工廠建設項目”。上述項目截至2020年9月30日募集資金投入情況,及本次延期前後項目達到預定可使用狀態日期如下:


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.